CVS Corp (NYSE:CVS) shares traded -0.74% down during most recent session to reach at the closing price of $65.55. The stock exchanged hands 15.5 Million shares versus average trading capacity of 9.61 Million shares, yielding a market cap of $83.2 Billion. Wall Street analysts covering the stock are projecting that the stock will reach $92.41 within the next 52-weeks. The mean target projections are based on 22 opinions.
Taking a broader look brokerage firms’ analysts on the street with an expectant view have CVS Corp (NYSE:CVS) high price target of $106 and with a conservative view have low price target of $76.
Barclays “Initiates Coverage On” CVS Corp (NYSE:CVS) in a research note issued to investors on 12/18/18 to Overweight with price target of $91.
Additionally on 11/29/18 Goldman Sachs “Reinstates” CVS Corp (NYSE:CVS) to Neutral setting price target at $87 and on 11/27/18 Cantor Fitzgerald “Initiates Coverage On” the stock to Overweight at $96. Furthermore on 10/26/18 Wolfe Research “Initiates Coverage On” the stock to Peer Perform at $0.
On the other hand the company has Relative Strength Index (RSI 14) of 35.44 along with Average True Range (ATR 14) of 2.28, Consequently CVS Corp (NYSE:CVS)’s weekly and monthly volatility is 3.54%, 3.32% respectively. The company’s beta value is at 1.1.
In terms of Buy, Sell or Hold recommendations, CVS Corp (NYSE:CVS) has analysts’ mean recommendation of 1.9. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.
According to analysts CVS Corp (NYSE:CVS)’s minimum EPS for the current quarter is at $1.82 and can go high up to $2.16. The consensus mean EPS for the current quarter is at $2.04 derived from a total of 9 estimates from the analysts who have weighed in on projected earnings. However the company reported $1.92 earnings per share for the same quarter during last year.
Previously CVS Corp (NYSE:CVS) reported $1.73 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.02. The company posted an earnings surprise of 1.2%.
CVS Corp (NYSE:CVS)’s revenue estimates for the current quarter are $54.63 Billion according to 9 number of analysts, for the current quarter the company has high revenue estimates of $62.12 Billion in contradiction of low revenue estimates of $52.48 Billion. For the current year the company’s revenue estimates are $193.93 Billion compared to low analyst estimates of $190.24 Billion and high estimates of $201.79 Billion according to 10 number of analysts.
Currently CVS Corp (NYSE:CVS)’s shares owned by insiders are 0.1%, whereas shares owned by institutional owners are 69.7%. However the six-month change in the insider ownership was recorded -16.65%, as well as three-month change in the institutional ownership was recorded 0.31%.
CVS Corp (NYSE:CVS)’s trailing twelve month revenues are $188.06 Billion, whereas its price to sales ratio for the same period is 0.44. Its book value per share for the most recent quarter is $35.9 while its price to book ratio for the same period is 1.83, as for as the company’s cash per share for the most recent quarter is $32.85, however its price to cash per share ratio for the same period is 2. The stock has 5 year expected PEG ratio of 3.33 whereas its trailing twelve month P/E ratio is 41.94.